Climb Bio, Inc. (CLYM) KPIs and segments
Close on Nov 16, 2026Market cap $570.92MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Climb Bio's business
Climb Bio's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
United Kingdom($M) | -0.27 | -6.76 | -17.4 | -39.0 | -34.2 | -15.6 | |
United States($M) | -59.6 | -67.1 | -17.8 | -6.27 | -13.3 | -5.08 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-03-05.
See a number that looks wrong?